Abstract
ObjectivesTo develop a new dye formulation for vitreoretinal surgery, which shows increased transparency for better intraoperative handling with better parameters important for use.Methods and analysisA new blue dye, DDG, was synthesised and tested for toxicity and staining. Diglycerol as new density-increasing additive was identified, and its toxicity and lack of influence of the staining with trypan blue (TB) on a collagen membrane as model for the epiretinal membrane was determined. Transparency of the dye solution was evaluated.ResultsDDG is as alternative to Brilliant Blue G (BBG), with good staining properties for interna limitans models, and a good safety profile. Diglycerol is a new non-toxic additive replacing PEG3350, with reduced viscosity and no reduction in staining, allowing the reduction of TB to achieve the same staining level of the collagen membrane by 40%, with greater transparency of the dye solution and reduced viscosity. Both factors should facilitate a safe removal during surgery.ConclusionA new dye preparation with improved performance in comparison to marketed combinations of BBG and TB was developed. Its reduced TB concentration and viscosity with maintained density allow better tolerance and handling.
Funder
Meyer-Schwarting Stiftung
Reference9 articles.
1. Enaida H , Hisatomi T , Ishibashi T . 2016 2016 patent EP 1 819 366 B2.
2. Lingenfelder C , Theisinger B , Hiebl W . Patent DE202009017759U1 2010.
3. Toxicity and phototoxicity in human ARPE-19 retinal pigment epithelium cells of dyes commonly used in retinal surgery;Awad;Eur J Ophthalmol,2018
4. ISO . Biological evaluation of medical devices — Part 5: tests for in vitro cytotoxicity. Geneva: Standardization IOf, 2009.
5. Glial cells and collagens in epiretinal membranes associated with idiopathic macular holes;Bu;Retina,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献